Letters
Co-trimoxazole and sudden death with RAS inhibitors
Link between co-trimoxazole and sudden death in patients receiving inhibitors of renin-angiotensin system could be due to confounding
BMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g6899 (Published 18 November 2014) Cite this as: BMJ 2014;349:g6899- Henk Scheper, fellow in infectious diseases1,
- Willem M Lijfering, clinical epidemiologist1
- 1Leiden University Medical Centre, 2333ZA Leiden, Netherlands
- H.scheper{at}lumc.nl
Fralick and colleagues’ case-control study investigated whether elderly people receiving renin angiotensin (RAS) inhibitors are at increased risk of death within 7-14 days of starting treatment with co-trimoxazole.1 However, their results could be flawed by confounding by indication. After extensive adjustment with a propensity score, co-trimaxozole users had a 1.38 (95% …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.